FDA Approves Dual-Energy Catheter Ablation Platform - Summary - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

FDA Approves Dual-Energy Catheter Ablation Platform

The platform integrates with the CARTO ecosystem and enables physicians to use either pulsed field or radiofrequency energy based on patient anatomy and case complexity.

  • By

  • Kathryn Wighton

  • July 8, 2026

  • 2 min

Share

Objective:

To announce the FDA approval of the Dual Energy THERMOCOOL SMARTTOUCH SF Platform for catheter ablation.

Approach:
  • Platform Overview: The platform allows delivery of both pulsed field and radiofrequency energy through a single catheter.
  • Integration: It is integrated with the CARTO ecosystem, which includes mapping, imaging, and pulsed field index guidance.
Key Findings:
  • The platform is built on the THERMOCOOL SMARTTOUCH SF catheter platform, used in over one million US patients.
  • It enables precise contact force delivery of energy tailored to patient anatomy and case complexity.
  • First US procedures are expected to begin this summer as part of a phased rollout.
Interpretation:

The platform provides electrophysiologists with the flexibility to choose between RF and PF energy based on procedural needs.

Limitations:
  • Dhanunjaya Lakkireddy, MD, FHRS, MBA, is a consultant for Johnson & Johnson and was not compensated for his contribution to the announcement.
Conclusion:

The Dual Energy THERMOCOOL SMARTTOUCH SF Platform aims to enhance procedural confidence and adaptability in complex cases.

Sources:

Original Source(s)

FDA Approves Dual-Energy Catheter Ablation Platform

  • by Kathryn Wighton

  • July 8, 2026

Related Content

Bicarbonate in Cardiac Arrest: Any Benefit?

A first-of-its-kind randomized trial in in-hospital cardiac arrest found no statistically significant increase in sustained return of spontaneous circulation with sodium bicarbonate vs placebo.

Adenosine Dose and Cardioversion in Pediatric Supraventricular Tachycardia: A Systematic Review and Meta-Analysis

Could Pregnancy Complications Predict CVD Risk?

Investigators found that adding pregnancy-related and female-specific factors modestly improved postpartum cardiovascular risk prediction compared with traditional risk factors alone.